Drug profile · INN
lasofoxifene
FABLYN
lasofoxifene (FABLYN) is a estrogen receptor modulator.
EMA: unknown Genito-urinary system and sex hormones (G03) G03
Patents linked 0
Pipeline programs 3
News articles 1
Drug details — lasofoxifene
- Class
- Genito-urinary system and sex hormones (G03)
- Route
- —
- Patents
- 0
- Programs
- 3
- Data quality
- 0.83
Quick answer
lasofoxifene (FABLYN) is a estrogen receptor modulator.
Key facts
INN lasofoxifene
Brand FABLYN
Mechanism Estrogen receptor modulator
Target Estrogen receptor
Therapeutic class Genito-urinary system and sex hormones (G03)
ATC code G03
Mechanism of action
Estrogen receptor modulator
Primary target: Estrogen receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | unknown | — |
Recent coverage
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is lasofoxifene?
lasofoxifene (FABLYN) is a estrogen receptor modulator.
What is the brand name for lasofoxifene?
FABLYN is a marketed brand name for lasofoxifene. Check FDA Drugs@FDA for the current US label holder and prescribing information.